Bio-Techne Corporation
US ˙ NasdaqGS ˙ US09073M1045

SecurityTECH / Bio-Techne Corporation
InstitutionBrown Capital Management Llc
Latest Disclosed Ownership1,702,424 shares
Ownership 4.51%
Brown Capital Management Llc ownership in TECH / Bio-Techne Corporation

2019-02-14 - Brown Capital Management Llc has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,702,424 shares of Bio-Techne Corporation (US:TECH). This represents 4.51 percent ownership of the company. In their previous filing dated 2018-02-14 , Brown Capital Management Llc had reported owning 2,025,700 shares, indicating a decrease of -15.96 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date
Effective
Date
Form Prev
Shares
Latest
Shares
ΔShares
(Percent)
Ownership
(Percent)
ΔOwnership
(Percent)
2019-02-14 2019-02-14 13G/A 2,025,700 1,702,424 -15.96 4.51 -16.64
2018-02-14 2018-02-14 13G/A 2,291,016 2,025,700 -11.58 5.41 -11.89
2017-02-09 2017-02-09 13G/A 2,452,328 2,291,016 -6.58 6.14 -6.83
2016-02-16 2016-02-16 13G/A 2,452,328 6.59
2015-02-05 2015-02-05 13G/A 2,332,040 6.29
2014-02-13 2014-02-13 13G/A 1,974,729 5.36
2013-11-07 2013-11-07 13G 1,911,614 5.19

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F BIO-TECHNE COM 09073M104 309,561 -126,080 -28.94 16,178 -36.86 2.2980
2026-02-17 2025-12-31 13F BIO-TECHNE COM 09073M104 435,641 -600,289 -57.95 25,620 -55.54 2.1015
2025-11-04 2025-09-30 13F BIO-TECHNE COM 09073M104 1,035,930 -537,673 -34.17 57,629 -28.82 2.3750
2025-08-13 2025-06-30 13F BIO-TECHNE COM 09073M104 1,573,603 -94,825 -5.68 80,962 -17.23 2.3548
2025-05-15 2025-03-31 13F BIO-TECHNE COM 09073M104 1,668,428 -179,294 -9.70 97,820 -26.50 2.9484
2025-02-14 2024-12-31 13F BIO-TECHNE COM 09073M104 1,847,722 -262,492 -12.44 133,091 -21.09 3.0840
2024-11-12 2024-09-30 13F BIO-TECHNE COM 09073M104 2,110,214 -319,334 -13.14 168,669 -3.11 3.6295
2024-08-12 2024-06-30 13F BIO-TECHNE COM 09073M104 2,429,548 -137,632 -5.36 174,077 -3.67 3.5172
2024-05-15 2024-03-31 13F BIO-TECHNE COM 09073M104 2,567,180 -983,810 -27.71 180,704 -34.05 3.1982
2024-02-14 2023-12-31 13F BIO-TECHNE COM 09073M104 3,550,990 392,986 12.44 273,994 27.46 4.1112
2023-11-14 2023-09-30 13F BIO-TECHNE COM 09073M104 3,158,004 -2,888 -0.09 214,965 -16.69 3.2949
2023-08-14 2023-06-30 13F BIO-TECHNE COM 09073M104 3,160,892 -101,485 -3.11 258,024 6.61 3.6604
2023-05-15 2023-03-31 13F BIO-TECHNE COM 09073M104 3,262,377 -39,115 -1.18 242,036 -11.55 3.6176
2023-02-14 2022-12-31 13F BIO-TECHNE COM 09073M104 3,301,492 2,478,189 301.01 273,628 17.03 4.5261
2022-11-14 2022-09-30 13F BIO-TECHNE COM 09073M104 823,303 -16,284 -1.94 233,818 -19.66 3.2782
2022-08-15 2022-06-30 13F BIO-TECHNE COM 09073M104 839,587 -78,741 -8.57 291,034 -26.82 3.8969
2022-05-16 2022-03-31 13F BIO-TECHNE COM 09073M104 918,328 -68,475 -6.94 397,673 -22.10 3.9576
2022-02-14 2021-12-31 13F BIO-TECHNE COM 09073M104 986,803 -14,807 -1.48 510,513 5.18 4.2239
2021-11-15 2021-09-30 13F BIO-TECHNE COM 09073M104 1,001,610 -82,262 -7.59 485,350 -0.55 3.9745
2021-08-16 2021-06-30 13F BIO-TECHNE COM 09073M104 1,083,872 -257,275 -19.18 488,024 -4.72 3.6987
2021-05-14 2021-03-31 13F BIO-TECHNE COM 09073M104 1,341,147 -157,086 -10.48 512,224 7.66 3.8130
2021-02-16 2020-12-31 13F BIO-TECHNE COM 09073M104 1,498,233 -30,621 -2.00 475,764 25.62 3.2871
2020-11-13 2020-09-30 13F BIO-TECHNE COM 09073M104 1,528,854 -2,396 -0.16 378,743 -6.33 3.1392
2020-08-07 2020-06-30 13F/A-1 BIO-TECHNE COM 09073M104 1,531,250 -25,233 -1.62 404,357 37.01 3.4765
2020-07-22 2020-06-30 13F BIO-TECHNE COM 09073M104 1,556,483 0 295,140 3,421,115.3782
2020-05-08 2020-03-31 13F BIO-TECHNE COM 09073M104 1,556,483 -84,914 -5.17 295,140 -18.09 3.4211
2020-02-14 2019-12-31 13F BIO TECHNE COM 09073M104 1,641,397 2,850 0.17 360,303 12.38 3.4458
2019-11-13 2019-09-30 13F BIO TECHNE COM 09073M104 1,638,547 -400 -0.02 320,614 -6.17 3.1112
2019-08-13 2019-06-30 13F BIO TECHNE COM 09073M104 1,638,947 -31,752 -1.90 341,704 3.01 3.2412
2019-05-15 2019-03-31 13F BIO TECHNE COM 09073M104 1,670,699 -31,725 -1.86 331,717 34.64 3.3541
2019-02-14 2018-12-31 13F BIO TECHNE COM 09073M104 1,702,424 -365,684 -17.68 246,375 -41.63 2.9647
2018-11-14 2018-09-30 13F BIO TECHNE COM 09073M104 2,068,108 87,326 4.41 422,122 44.04 3.8342
2018-08-14 2018-06-30 13F BIO TECHNE COM 09073M104 1,980,782 -8,779 -0.44 293,057 -2.48 3.0068
2018-05-15 2018-03-31 13F BIO TECHNE COM 09073M104 1,989,561 -36,139 -1.78 300,503 14.51 3.4119
2018-02-14 2017-12-31 13F BIO TECHNE COM 09073M104 2,025,700 -93,407 -4.41 262,429 2.44 3.1857
2017-11-14 2017-09-30 13F BIO TECHNE COM 09073M104 2,119,107 -28,221 -1.31 256,179 1.53 3.1174
2017-08-14 2017-06-30 13F BIO TECHNE COM 09073M104 2,147,328 -362 -0.02 252,311 15.57 3.0915
2017-05-09 2017-03-31 13F BIO TECHNE COM 09073M104 2,147,690 -143,326 -6.26 218,313 -7.33 2.9115
2017-02-08 2016-12-31 13F BIO TECHNE COM 09073M104 2,291,016 30,963 1.37 235,585 -4.80 3.4396
2016-11-14 2016-09-30 13F BIO TECHNE COM 09073M104 2,260,053 546 0.02 247,476 -2.88 3.6384
2016-08-04 2016-06-30 13F BIO TECHNE COM 09073M104 2,259,507 -228,771 -9.19 254,805 8.34 4.0261
2016-05-16 2016-03-31 13F BIO TECHNE COM 09073M104 2,488,278 35,950 1.47 235,192 6.56 3.8927
2016-02-16 2015-12-31 13F BIO TECHNE COM 09073M104 2,452,328 14,170 0.58 220,710 -2.09 3.4572
2015-11-16 2015-09-30 13F BIO TECHNE COM 09073M104 2,438,158 120,892 5.22 225,432 -1.20 3.8632
2015-08-13 2015-06-30 13F BIO TECHNE COM 09073M104 2,317,266 -24 -0.00 228,181 -1.82 3.7556
2015-05-15 2015-03-31 13F BIO TECHNE COM 09073M104 2,317,290 -14,750 -0.63 232,401 7.85 3.8341
2015-02-13 2014-12-31 13F BIO TECHNE COM 09073M104 2,332,040 97,032 4.34 215,480 3.06 3.7203
2014-11-14 2014-09-30 13F TECHNE COM 878377100 2,235,008 155,131 7.46 209,085 8.60 3.7034
2014-08-11 2014-06-30 13F TECHNE COM 878377100 2,079,877 -89,150 -4.11 192,534 3.98 3.2059
2014-05-13 2014-03-31 13F Techne COM 878377100 2,169,027 194,298 9.84 185,170 -0.95 3.0522
2014-02-12 2013-12-31 13F TECHNE COM 878377100 1,974,729 166,069 9.18 186,948 29.11 3.0620
2013-11-14 2013-09-30 13F TECHNE COM 878377100 1,808,660 -13,824 -0.76 144,801 15.02 2.5515
2013-08-14 2013-06-30 13F TECHNE COM 878377100 1,822,484 1,822,484 125,897 2.6962
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.